NCT03411876View on ClinicalTrials.gov

Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 18, 2018

Primary Completion Date

January 15, 2019

Study Completion Date

January 15, 2019

Conditions
Idiopathic Pulmonary FibrosisHypoxemia
Interventions
DEVICE

Oxymizer® pendant nasal cannula

Supplemental oxygen is provided by an Oxymizer pendant nasal cannula.

DEVICE

conventional nasal cannula

Supplemental oxygen is provided by a conventional nasal cannula.

Trial Locations (1)

Unknown

Schön Klinik Berchtesgadener Land, Schönau am Königssee

All Listed Sponsors
collaborator

Schön Klinik Berchtesgadener Land

OTHER

lead

Klaus Kenn

OTHER

NCT03411876 - Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter